Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Hypertension (Dallas, Tex. : 1979)|August 24, 1999
Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneityB S Tea, T V Dam, P Moreau, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1997
Smooth muscle apoptosis during vascular regression in spontaneously hypertensive ratsD deBlois, B S Tea, V D Than, et al.
Journal of Hypertension|October 26, 2001
Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependentH H Dao, J Lemay, J de Champlain, et al.
Hypertension (Dallas, Tex. : 1979)|May 20, 2000
Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivoB S Tea, S Der Sarkissian, R M Touyz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Effect of phosphorothioated oligonucleotides on neointima formation in the rat carotid artery. Dissecting the mechanism of actionM R Bennett, V Lindner, D DeBlois, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 1, 1996
Smooth muscle DNA replication in response to angiotensin II is regulated differently in the neointima and media at different times after balloon injury in the rat carotid artery. Role of AT1 receptor expressionD deBlois, M Viswanathan, J E Su, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1997
Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudationL Liaw, D M Lombardi, M M Almeida, et al.
Circulation Research|November 1, 1990
Contractile effect of the chemotactic factors f-Met-Leu-Phe and C5a on the human isolated umbilical artery. Role of cyclooxygenase products and tissue macrophagesF Marceau, D deBlois, C Laplante, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1996
Angiotensin II induction of osteopontin expression and DNA replication in rat arteriesD deBlois, D M Lombardi, E J Su, et al.
British Journal of Pharmacology|December 7, 2007
Control of left ventricular mass by moxonidine involves reduced DNA synthesis and enhanced DNA fragmentationP-A Paquette, D Duguay, R El-Ayoubi, et al.
Pageof 4